U.S. Markets open in 8 hrs 41 mins

Here Are Amicus’s Key Research Programs in 2019

Margaret Patrick
Here Are Amicus’s Key Research Programs in 2019

Amicus or Portola: Which Is the Best Bet in May?(Continued from Prior Part)Vision for fiscal 2023In its investor presentation, Amicus Therapeutics (FOLD) has guided for revenues of around $200 million and $300 million for its AT-GAA Novel ERT